Nonacus Ltd, a leading provider of ultra-sensitive next-generation sequencing (NGS) products, has been awarded the NHS All Wales Medical Genomic Services (AWMGS) tender for familial hypercholesterolemia (FH) testing. The new contract involves the supply of Nonacus' NGS custom-designed panels for clinical use in FH testing. This makes another significant step in the partnership between Nonacus and NHS Wales.
This achievement highlights the growing adoption of Nonacus’ custom NGS solutions within routine clinical services. The bespoke design of these panels allows healthcare providers to tailor genetic testing to meet specific clinical needs, delivering highly accurate and reliable results. This has proven particularly valuable for the early diagnosis and treatment of FH. FH is a genetic condition affecting 34 million people worldwide, 90% of whom remain undiagnosed.1 Early identification and management are crucial to reducing the risk of heart disease associated with high cholesterol levels in FH patients.
Justyna Tull, Head of the Technical Programme at AWMGS, commented:
“People with FH, if untreated, are at an increased risk of early coronary heart disease. Our FH cascading testing service has been a major step forward for patients with inherited high cholesterol offering an effective way of finding family members who also have FH. Working with the online design tool from Nonacus, we have been able to create a bespoke NGS panel that delivers the quality of data that we need for our service.”
Jeff Bousfield, CEO of Nonacus commented:
"We are excited to be selected by the All Wales Genetic Lab to support the delivery of their familial hypercholesterolaemia service. It adds to a growing number of NHS laboratories that have chosen our NGS panels for adoption into clinical service. We look forward to continuing to work with the All Wales Genetics Laboratory.”
The new contract underscores Nonacus' commitment to advancing genetic testing technologies and enhancing patient care through innovative solutions. As part of this ongoing partnership, Nonacus will continue to work closely with AWMGS to ensure the successful operation of the familial hypercholesterolemia testing service.
For more information, visit our Familial Hypercholesterolemia Collaboration page.
References
1. Familial Hypercholesterolemia, World Heart Federation, Accessed September 20, 2024